This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Guan, K.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Guan, K.-L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2004, p. 7965-7975, Vol. 24, No. 18
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.18.7965-7975.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity

Yong Li,1,2 Ken Inoki,1,2 and Kun-Liang Guan1,2,3*

Life Sciences Institute,1 Department of Biological Chemistry,2 Institute of Gerontology, University of Michigan, Ann Arbor, Michigan3

Received 18 May 2004/ Accepted 15 June 2004

Tuberous sclerosis complex (TSC) is a genetic disease caused by a mutation in either the tsc1 or tsc2 tumor suppressor gene. Recent studies have demonstrated that TSC2 displays GAP (GTPase-activating protein) activity specifically towards the small G protein Rheb and inhibits its ability to stimulate the mTOR signaling pathway. Rheb and TSC2 comprise a unique pair of GTPase and GAP, because Rheb has high basal GTP levels and TSC2 does not have the catalytic arginine finger found in Ras-GAP. To investigate the function of TSC2 and Rheb in mTOR signaling, we analyzed the TSC2-stimulated Rheb GTPase activity. We found that Arg15, a residue equivalent to Gly12 in Ras, is important for Rheb to function as a substrate for TSC2 GAP. In addition, we identified asparagine residues essential for TSC2 GAP activity. We demonstrated a novel catalytic mechanism of the TSC2 GAP and Rheb that TSC2 uses a catalytic "asparagine thumb" instead of the arginine finger found in Ras-GAP. Furthermore, we discovered that farnesylation and membrane localization of Rheb is not essential for Rheb to stimulate S6 kinase (S6K) phosphorylation. Analysis of TSC1 binding defective mutants of TSC2 shows that TSC1 is not required for the TSC2 GAP activity but may function as a regulatory component in the TSC1/TSC2 complex. Our data further demonstrate that GAP activity is essential for the cellular function of TSC2 to inhibit S6K phosphorylation.

* Corresponding author. Mailing address: Life Sciences Institute, University of Michigan, 5450 Medical Science I Building, Ann Arbor, MI 48109-0606. Phone: (734) 763-3030. Fax: (734) 647-9702. E-mail: kunliang{at}umich.edu.

Molecular and Cellular Biology, September 2004, p. 7965-7975, Vol. 24, No. 18
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.18.7965-7975.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Goncharova, E. A., Goncharov, D. A., Damera, G., Tliba, O., Amrani, Y., Panettieri, R. A. Jr., Krymskaya, V. P. (2009). Signal Transducer and Activator of Transcription 3 Is Required for Abnormal Proliferation and Survival of TSC2-Deficient Cells: Relevance to Pulmonary Lymphangioleiomyomatosis. Mol. Pharmacol. 76: 766-777 [Abstract] [Full Text]  
  • Murai, T., Nakase, Y., Fukuda, K., Chikashige, Y., Tsutsumi, C., Hiraoka, Y., Matsumoto, T. (2009). Distinctive Responses to Nitrogen Starvation in the Dominant Active Mutants of the Fission Yeast Rheb GTPase. Genetics 183: 517-527 [Abstract] [Full Text]  
  • Cao, P., Hanai, J.-i., Tanksale, P., Imamura, S., Sukhatme, V. P., Lecker, S. H. (2009). Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J. 23: 2844-2854 [Abstract] [Full Text]  
  • Shirakawa, R., Fukai, S., Kawato, M., Higashi, T., Kondo, H., Ikeda, T., Nakayama, E., Okawa, K., Nureki, O., Kimura, T., Kita, T., Horiuchi, H. (2009). Tuberous Sclerosis Tumor Suppressor Complex-like Complexes Act as GTPase-activating Proteins for Ral GTPases. J. Biol. Chem. 284: 21580-21588 [Abstract] [Full Text]  
  • Lee, M. N., Ha, S. H., Kim, J., Koh, A., Lee, C. S., Kim, J. H., Jeon, H., Kim, D.-H., Suh, P.-G., Ryu, S. H. (2009). Glycolytic Flux Signals to mTOR through Glyceraldehyde-3-Phosphate Dehydrogenase-Mediated Regulation of Rheb. Mol. Cell. Biol. 29: 3991-4001 [Abstract] [Full Text]  
  • Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Pende, M., Daegelen, D., Sakamoto, K., Foretz, M., Viollet, B. (2009). Important role for AMPK{alpha}1 in limiting skeletal muscle cell hypertrophy. FASEB J. 23: 2264-2273 [Abstract] [Full Text]  
  • Finlay, G. A., Malhowski, A. J., Polizzi, K., Malinowska-Kolodziej, I., Kwiatkowski, D. J. (2009). Renal and liver tumors in Tsc2+/- mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Molecular Cancer Therapeutics 8: 1799-1807 [Abstract] [Full Text]  
  • Beevers, C. S., Chen, L., Liu, L., Luo, Y., Webster, N. J.G., Huang, S. (2009). Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex. Cancer Res. 69: 1000-1008 [Abstract] [Full Text]  
  • Marshall, C. B., Ho, J., Buerger, C., Plevin, M. J., Li, G.-Y., Li, Z., Ikura, M., Stambolic, V. (2009). Characterization of the Intrinsic and TSC2-GAP-Regulated GTPase Activity of Rheb by Real-Time NMR. Sci Signal 2: ra3-ra3 [Abstract] [Full Text]  
  • Wang, X., Fonseca, B. D., Tang, H., Liu, R., Elia, A., Clemens, M. J., Bommer, U.-A., Proud, C. G. (2008). Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling. J. Biol. Chem. 283: 30482-30492 [Abstract] [Full Text]  
  • Buller, C. L., Loberg, R. D., Fan, M.-H., Zhu, Q., Park, J. L., Vesely, E., Inoki, K., Guan, K.-L., Brosius, F. C. III (2008). A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am. J. Physiol. Cell Physiol. 295: C836-C843 [Abstract] [Full Text]  
  • Sun, Y., Fang, Y., Yoon, M.-S., Zhang, C., Roccio, M., Zwartkruis, F. J., Armstrong, M., Brown, H. A., Chen, J. (2008). Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc. Natl. Acad. Sci. USA 105: 8286-8291 [Abstract] [Full Text]  
  • Habib, S. L., Riley, D. J., Mahimainathan, L., Bhandari, B., Choudhury, G. G., Abboud, H. E. (2008). Tuberin regulates the DNA repair enzyme OGG1. Am. J. Physiol. Renal Physiol. 294: F281-F290 [Abstract] [Full Text]  
  • Li, Y., Wang, Y., Kim, E., Beemiller, P., Wang, C.-Y., Swanson, J., You, M., Guan, K.-L. (2007). Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with Rheb. J. Biol. Chem. 282: 35803-35813 [Abstract] [Full Text]  
  • Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., Jiang, Y. (2007). Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38. Science 318: 977-980 [Abstract] [Full Text]  
  • Finlay, G. A., Malhowski, A. J., Liu, Y., Fanburg, B. L., Kwiatkowski, D. J., Toksoz, D. (2007). Selective Inhibition of Growth of Tuberous Sclerosis Complex 2 Null Cells by Atorvastatin Is Associated with Impaired Rheb and Rho GTPase Function and Reduced mTOR/S6 Kinase Activity. Cancer Res. 67: 9878-9886 [Abstract] [Full Text]  
  • Land, S. C., Tee, A. R. (2007). Hypoxia-inducible Factor 1{alpha} Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif. J. Biol. Chem. 282: 20534-20543 [Abstract] [Full Text]  
  • Juvet, S. C., McCormack, F. X., Kwiatkowski, D. J., Downey, G. P. (2007). Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans. Am. J. Respir. Cell Mol. Bio. 36: 398-408 [Abstract] [Full Text]  
  • Cao, Y., Kamioka, Y., Yokoi, N., Kobayashi, T., Hino, O., Onodera, M., Mochizuki, N., Nakae, J. (2006). Interaction of FoxO1 and TSC2 Induces Insulin Resistance through Activation of the Mammalian Target of Rapamycin/p70 S6K Pathway. J. Biol. Chem. 281: 40242-40251 [Abstract] [Full Text]  
  • Matsushima, R., Harada, N., Webster, N. J. G., Tsutsumi, Y. M., Nakaya, Y. (2006). Effect of TRB3 on Insulin and Nutrient-stimulated Hepatic p70 S6 Kinase Activity. J. Biol. Chem. 281: 29719-29729 [Abstract] [Full Text]  
  • Shah, O. J., Hunter, T. (2006). Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis.. Mol. Cell. Biol. 26: 6425-6434 [Abstract] [Full Text]  
  • Yan, L., Findlay, G. M., Jones, R., Procter, J., Cao, Y., Lamb, R. F. (2006). Hyperactivation of Mammalian Target of Rapamycin (mTOR) Signaling by a Gain-of-Function Mutant of the Rheb GTPase. J. Biol. Chem. 281: 19793-19797 [Abstract] [Full Text]  
  • Nakase, Y., Fukuda, K., Chikashige, Y., Tsutsumi, C., Morita, D., Kawamoto, S., Ohnuki, M., Hiraoka, Y., Matsumoto, T. (2006). A Defect in Protein Farnesylation Suppresses a Loss of Schizosaccharomyces pombe tsc2+, a Homolog of the Human Gene Predisposing to Tuberous Sclerosis Complex. Genetics 173: 569-578 [Abstract] [Full Text]  
  • Goncharova, E. A., Goncharov, D. A., Spaits, M., Noonan, D. J., Talovskaya, E., Eszterhas, A., Krymskaya, V. P. (2006). Abnormal Growth of Smooth Muscle-Like Cells in Lymphangioleiomyomatosis: Role for Tumor Suppressor TSC2. Am. J. Respir. Cell Mol. Bio. 34: 561-572 [Abstract] [Full Text]  
  • Cai, S.-L., Tee, A. R., Short, J. D., Bergeron, J. M., Kim, J., Shen, J., Guo, R., Johnson, C. L., Kiguchi, K., Walker, C. L. (2006). Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. JCB 173: 279-289 [Abstract] [Full Text]  
  • Kimball, S. R, Jefferson, L. S (2006). New functions for amino acids: effects on gene transcription and translation. Am. J. Clin. Nutr. 83: 500S-507S [Abstract] [Full Text]  
  • Kaper, F., Dornhoefer, N., Giaccia, A. J. (2006). Mutations in the PI3K/PTEN/TSC2 Pathway Contribute to Mammalian Target of Rapamycin Activity and Increased Translation under Hypoxic Conditions. Cancer Res. 66: 1561-1569 [Abstract] [Full Text]  
  • Tzatsos, A., Kandror, K. V. (2006). Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation. Mol. Cell. Biol. 26: 63-76 [Abstract] [Full Text]  
  • Kimball, S. R., Jefferson, L. S. (2006). Signaling Pathways and Molecular Mechanisms through which Branched-Chain Amino Acids Mediate Translational Control of Protein Synthesis. J. Nutr. 136: 227S-231S [Abstract] [Full Text]  
  • Zacharek, S. J., Xiong, Y., Shumway, S. D. (2005). Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins. Cancer Res. 65: 11354-11360 [Abstract] [Full Text]  
  • Dekanty, A., Lavista-Llanos, S., Irisarri, M., Oldham, S., Wappner, P. (2005). The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-{alpha}/Sima. J. Cell Sci. 118: 5431-5441 [Abstract] [Full Text]  
  • Takahashi, K., Nakagawa, M., Young, S. G., Yamanaka, S. (2005). Differential Membrane Localization of ERas and Rheb, Two Ras-related Proteins Involved in the Phosphatidylinositol 3-Kinase/mTOR Pathway. J. Biol. Chem. 280: 32768-32774 [Abstract] [Full Text]  
  • Basso, A. D., Mirza, A., Liu, G., Long, B. J., Bishop, W. R., Kirschmeier, P. (2005). The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling: ROLE IN FTI ENHANCEMENT OF TAXANE AND TAMOXIFEN ANTI-TUMOR ACTIVITY. J. Biol. Chem. 280: 31101-31108 [Abstract] [Full Text]  
  • Sofer, A., Lei, K., Johannessen, C. M., Ellisen, L. W. (2005). Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1. Mol. Cell. Biol. 25: 5834-5845 [Abstract] [Full Text]  
  • Long, X., Ortiz-Vega, S., Lin, Y., Avruch, J. (2005). Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency. J. Biol. Chem. 280: 23433-23436 [Abstract] [Full Text]  
  • Gau, C.-L., Kato-Stankiewicz, J., Jiang, C., Miyamoto, S., Guo, L., Tamanoi, F. (2005). Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways. Molecular Cancer Therapeutics 4: 918-926 [Abstract] [Full Text]  
  • Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J., Proud, C. G. (2005). The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses. J. Biol. Chem. 280: 18717-18727 [Abstract] [Full Text]  
  • Yu, Y., Li, S., Xu, X., Li, Y., Guan, K., Arnold, E., Ding, J. (2005). Structural Basis for the Unique Biological Function of Small GTPase RHEB. J. Biol. Chem. 280: 17093-17100 [Abstract] [Full Text]  
  • Scheidenhelm, D. K., Cresswell, J., Haipek, C. A., Fleming, T. P., Mercer, R. W., Gutmann, D. H. (2005). Akt-Dependent Cell Size Regulation by the Adhesion Molecule on Glia Occurs Independently of Phosphatidylinositol 3-Kinase and Rheb Signaling. Mol. Cell. Biol. 25: 3151-3162 [Abstract] [Full Text]  
  • Inoki, K., Ouyang, H., Li, Y., Guan, K.-L. (2005). Signaling by Target of Rapamycin Proteins in Cell Growth Control. Microbiol. Mol. Biol. Rev. 69: 79-100 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»